In 2012 a study by Joel Lexchin was published on the influence of the pharmaceutical industry on the outcomes of clinical trials. The study concludes that these companies skew the results in their favor at every stage of its production, and that there is no evidence that any measures taken to address this issue has stopped or even slowed down the biasing of this research.

Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications

pharmaceutical companies have used techniques leading to bias in the content of clinical research at every stage in its production.

…

There is no evidence that any measures that have been taken so far have stopped the biasing of clinical research and it’s not clear that they have even slowed down the process.

For the next article in the series, go to https://www.modernsamurai.info/pas20230905/

Further Reading

Lexchin, J. Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. Sci Eng Ethics 18, 247–261 (2012). https://doi.org/10.1007/s11948-011-9265-3